Show notes
Anthony Miller speaks with Dr. James Flewellen, co-founder and CEO of Kahu SiliconBio, about the company’s £1.2 million SPRIN-D funding and its shift from environmental sensing toward continuous hormone monitoring for women’s health. The conversation explains the underlying microbial electronic interface, why the pivot is more of a natural extension than a reset, and what the team plans to deliver over the next year.
This podcast is also available on the BritChips YouTube channel and in audio form on Apple Podcasts and Spotify.
Key topics
* James Flewellen explains Kahu SiliconBio’s core…
Website: anttheantidote.substack.com

